9-133208549-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014581.4(OBP2B):c.126G>T(p.Glu42Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014581.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OBP2B | ENST00000372034.8 | c.126G>T | p.Glu42Asp | missense_variant | 2/7 | 1 | NM_014581.4 | ENSP00000361104.3 | ||
OBP2B | ENST00000618116.4 | c.126G>T | p.Glu42Asp | missense_variant | 2/7 | 1 | ENSP00000484615.1 | |||
OBP2B | ENST00000473737.5 | n.126G>T | non_coding_transcript_exon_variant | 2/8 | 1 | ENSP00000434927.1 | ||||
OBP2B | ENST00000461961.2 | n.115-346G>T | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000363 AC: 9AN: 247740Hom.: 0 AF XY: 0.0000523 AC XY: 7AN XY: 133920
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461104Hom.: 0 Cov.: 35 AF XY: 0.0000413 AC XY: 30AN XY: 726798
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.126G>T (p.E42D) alteration is located in exon 2 (coding exon 2) of the OBP2B gene. This alteration results from a G to T substitution at nucleotide position 126, causing the glutamic acid (E) at amino acid position 42 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at